eLearning in less than 60 minutes

Changes/additions to materials:

MeReC Stop Press on NICE Clinical Guideline 59. 

NICE published its guidance on management of osteoarthritis in February 2008. The important changes are discussed in the MeReC Stop Press, which should be read in conjunction with the materials in this room of NPCi.

MeReC Rapid Review on glucosamine.

Recent evidence around glucosamine has emerged and we have tried to put this into the context of the new NICE guidance – the MeReC Rapid Review on this should also be read.

Lumiracoxib licence suspended

On 19th November 2007, the Medicines and Healthcare products Regulatory Agency (MHRA) suspended the licence for Prexige (lumiracoxib) due to the safety concerns about possible liver damage for patients. More information is available from the MHRA website here.

In this room you will find a series of workshops using a multimedia presentation of PowerPoint slides with audio commentary by the NPC team. You will need speakers and a sound card in your computer.

There's a lot of evidence about NSAIDs, it is complex and has been published piecemeal. We have summarised this into what we believe is a fair, balanced and accurate summary of the current position. But unfortunately we haven't been able to keep to our plan of "everything you need to know about X in less than 60 minutes". The workshops are each around 20 minutes - in keeping with the "bite-sized chunks" philosophy - and an outline of the content of each workshop is given below. Simply click on one of the underlined links and then click on the play icon to begin. You can jump forwards to skip a slide or backwards to repeat a slide by clicking the relevant slide on the left hand side of the console.

Workshop 1 - Setting the scene (8min 49secs)

• Prevalence, pathology and disease burden of OA
• How can we measure musculoskeletal pain?
• What are NSAIDs used for?

Workshop 2 - Options for musculoskeletal pain A (17min 15secs)

• non-drug therapies
• topical agents

Workshop 3 - Options for musculoskeletal pain B (16min 10secs)

• oral NSAIDs
• analgesics

Workshop 4a - What are the GI risks of NSAIDs? (19min 19secs)

• The extent of the problem, the relative risks of different traditional NSAIDs and the role of gastroprotective agents

Workshop 4b - What are the GI risks of NSAIDs? (23min 37secs)

• The role of the coxibs, etodolac and meloxicam

Workshop 5 - What are the CV and renal risks of NSAIDs? (30min 07secs)

Workshop 6 - What are the implications for practice? (21min 52secs)